Programmed cell death protein 4 (pdcd4): a novel target for antineoplastic therapy?
about
Interactome mapping suggests new mechanistic details underlying Alzheimer's diseaseLarge-scale mapping of human protein-protein interactions by mass spectrometryProgrammed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1)Cryptocaryol Structure-Activity Relationship Study of Cancer Cell Cytotoxicity and Ability to Stabilize PDCD4An essential role of PDCD4 in vascular smooth muscle cell apoptosis and proliferation: implications for vascular diseaseProgrammed cell death-4 deficiency prevents diet-induced obesity, adipose tissue inflammation, and insulin resistance.Cycling exercise affects the expression of apoptosis-associated microRNAs after spinal cord injury in rats.Knockdown of Pdcd4 results in induction of proprotein convertase 1/3 and potent secretion of chromogranin A and secretogranin II in a neuroendocrine cell line.MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3.Atheroprotective pulsatile flow induces ubiquitin-proteasome-mediated degradation of programmed cell death 4 in endothelial cells.Prognostic Implications of MicroRNA-21 Overexpression in Invasive Ductal Carcinomas of the Breast.IL-10 -1082 SNP and IL-10 in primary CNS and vitreoretinal lymphomas.Inhibition of NF-κB by deoxycholic acid induces miR-21/PDCD4-dependent hepatocelular apoptosis.Pdcd4 restrains the self-renewal and white-to-beige transdifferentiation of adipose-derived stem cells.Delayed ischemic preconditioning contributes to renal protection by upregulation of miR-21The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation.Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancer.Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma.Selective Hyaluronan-CD44 Signaling Promotes miRNA-21 Expression and Interacts with Vitamin D Function during Cutaneous Squamous Cell Carcinomas Progression Following UV IrradiationCurrent Status and Perspectives Regarding LNA-Anti-miR Oligonucleotides and microRNA miR-21 Inhibitors as a Potential Therapeutic Option in Treatment of Colorectal Cancer.Suppression of programmed cell death 4 (PDCD4) protein expression by BCR-ABL-regulated engagement of the mTOR/p70 S6 kinase pathway.Programmed cell death 4 mechanism of action: the model to be updated?FAT1 acts as an upstream regulator of oncogenic and inflammatory pathways, via PDCD4, in glioma cells.Expression patterns of programmed cell death 4 protein in normal human skin and some representative skin lesions.Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma.Total Synthesis of Cryptocaryol A by Enantioselective Iridium-Catalyzed Alcohol C-H Allylation.Gene expression profiles in HEK-293 cells with low or high store-operated calcium entry: can regulatory as well as regulated genes be identified?Camptothecin-induced expression of programmed cell death gene 11 in Spodoptera litura.HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma.Peroxisome proliferator-activated receptor-γ enhances human pulmonary artery smooth muscle cell apoptosis through microRNA-21 and programmed cell death 4.The Expression of PDCD4 in Patients With Missed Abortion and Its Clinical Significance.The inhibitory action of PDCD4 in lipopolysaccharide/D-galactosamine-induced acute liver injury.Identifying Involvement of H19-miR-675-3p-IGF1R and H19-miR-200a-PDCD4 in Treating Pulmonary Hypertension with Melatonin
P2860
Q24317038-51F92292-BB61-4DEE-88B8-16BDE92E6AF7Q24670192-764D1D58-D92B-42B6-9C44-4B8A85A42539Q28277655-FBED0635-C717-4055-91CA-F62EB351F098Q28386392-98DEC350-C663-4637-968A-DD05BD01ECDDQ28578102-E83378B0-43A1-435F-8A83-C791F2E267BAQ30557551-2D371A79-C699-456C-8B25-A831D1B5E400Q34235128-515DBDC2-7A5E-4B81-8B89-12C9F3C1C712Q34786163-33227390-65CF-4813-84B7-9687E796AA0CQ35070803-46A0799F-EF48-4F2E-AE01-FF7C1C882469Q35120296-28C42EEA-5EAA-4257-8E48-B5AD1A80C16AQ35713817-6A40B96B-CD08-48E6-A6B2-559B57B837A1Q36312982-CD45B843-020E-49BF-845A-2DBD43DF0D63Q36333430-7DFD1E83-7492-4F15-8F1D-DC36C735A60EQ36775060-CE3EB57D-11D2-4C1B-B1D9-2F7A05F04ECAQ37184698-9D723A0E-D278-43B3-8673-A47F5A10BC3AQ37438657-9ABC2D06-27C0-4F5C-BD34-134788D160A8Q38296989-8051E77C-D089-44A1-805E-82601A5013FAQ38331260-D6AA0A27-D9AE-41F7-B636-6D5CDE110219Q38510135-E6194395-FA7D-485B-B707-6D685FB9947DQ38841033-33F7C327-4DA7-43D3-BAAA-72E5C591CC19Q38923281-4EB4AF8D-07B9-4514-9571-BEDD7AE7286EQ39150619-2AF1E7EA-C3DD-40F3-AE4D-D8B2281A5980Q39276818-7510207D-EA05-4FC3-A855-A7AEF58AD54FQ40173606-D0CE6F45-A410-4441-B484-8AB55FE118FBQ40282309-A10C201E-B117-4B67-885B-2292D1F5F7B1Q40285034-C92581A2-1F63-45A5-82BA-071204D7CA8FQ40476372-51C4EE76-25C1-4D25-82EF-FC6243BD923DQ42008152-C93BA934-5FD7-45D3-8B0D-ECF3D6F2B694Q46669089-AFDCD648-2EC7-42D7-8E37-0FD029CD3147Q47074392-015EA5F2-EA8D-42C1-AD3F-6775F11E7675Q47826026-D4AE01A8-C557-4607-A344-0B5922E0A59BQ55461819-C69FADA6-FFB3-4251-B2BE-AE8C9A0A74F0Q58704509-FA21FE3B-25AF-4B23-A46F-40BC34F53F2A
P2860
Programmed cell death protein 4 (pdcd4): a novel target for antineoplastic therapy?
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Programmed cell death protein 4 (pdcd4): a novel target for antineoplastic therapy?
@ast
Programmed cell death protein 4 (pdcd4): a novel target for antineoplastic therapy?
@en
type
label
Programmed cell death protein 4 (pdcd4): a novel target for antineoplastic therapy?
@ast
Programmed cell death protein 4 (pdcd4): a novel target for antineoplastic therapy?
@en
prefLabel
Programmed cell death protein 4 (pdcd4): a novel target for antineoplastic therapy?
@ast
Programmed cell death protein 4 (pdcd4): a novel target for antineoplastic therapy?
@en
P1433
P1476
Programmed cell death protein 4 (pdcd4): a novel target for antineoplastic therapy?
@en
P2093
Brigitte Lankat-Buttgereit
Rüdiger Göke
P304
P356
10.1016/J.BIOLCEL.2003.09.003
P577
2003-11-01T00:00:00Z